Changjun Lv
Impact in
- Biochemistry top 0.5%
- Sulfur Compounds in Biology
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 43
- Neonatal Respiratory Health Research 7
-
- Circular RNAs in diseases 14
- RNA modifications and cancer 6
- Co-authors
- Lingxin Chen (17 shared papers)Fabiao Yu (9 shared papers)Min Gao (1 shared paper)Jaebum Choo (1 shared paper)Xiaodong Song (35 shared papers)Jinjin Zhang (26 shared papers)Meirong Wang (10 shared papers)Xinyu Song (5 shared papers)
- Journals
- Journal of Cellular and Molecular Medicine (9 papers)Scientific Reports (4 papers)Cell Death and Disease (4 papers)Journal of Materials Chemistry B (3 papers)BMC Pulmonary Medicine (3 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Changjun Lv
117 papers receiving 4.3k citations
Changjun Lv's Hit Papers
Peers
Comparison fields: 5 of 130
- Biochemistry 469
- Cancer Research 739
- Spectroscopy 581
- Pulmonary and Respiratory Medicine 912
- Molecular Biology 1.5k
Countries citing papers authored by Changjun Lv
This map shows the geographic impact of Changjun Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changjun Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changjun Lv more than expected).
Fields of papers citing papers by Changjun Lv
This network shows the impact of papers produced by Changjun Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changjun Lv. The network helps show where Changjun Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Changjun Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 122 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy Hit paper breakdown → | 2017 | 754 |
| 2 | 2014 | 168 | |
| 3 | 2017 | 122 | |
| 4 | 2021 | 106 | |
| 5 | 2013 | 98 | |
| 6 | 2018 | 86 | |
| 7 | 2019 | 84 | |
| 8 | 2011 | 82 | |
| 9 | 2014 | 80 | |
| 10 | 2019 | 80 | |
| 11 | 2022 | 78 | |
| 12 | 2013 | 69 | |
| 13 | 2015 | 64 | |
| 14 | 2017 | 63 | |
| 15 | 2013 | 63 | |
| 16 | 2013 | 61 | |
| 17 | 2015 | 60 | |
| 18 | 2018 | 59 | |
| 19 | 2018 | 59 | |
| 20 | 2013 | 58 |
About Changjun Lv
Changjun Lv is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Biochemistry and Epidemiology, having authored 122 papers that have together received 4.3k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (43 papers), Cancer-related molecular mechanisms research (15 papers), Circular RNAs in diseases (14 papers), MicroRNA in disease regulation (13 papers), Sulfur Compounds in Biology (8 papers), Neonatal Respiratory Health Research (7 papers), Molecular Sensors and Ion Detection (7 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Biochemistry (469 citations), Cancer Research (739 citations), Spectroscopy (581 citations), Pulmonary and Respiratory Medicine (912 citations) and Molecular Biology (1.5k citations). Changjun Lv has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Lingxin Chen, Fabiao Yu, Min Gao, Jaebum Choo, Xiaodong Song, Jinjin Zhang, Meirong Wang, Xinyu Song, Pan Xu and Xiaozhi Wang. Their work appears in journals such as Journal of Cellular and Molecular Medicine, Scientific Reports, Cell Death and Disease, Journal of Materials Chemistry B and BMC Pulmonary Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.